FK 409

Drug Profile

FK 409

Alternative Names: FR 900409; FR 900411

Latest Information Update: 17 Apr 2002

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Fujisawa; Nonindustrial source
  • Class Antiplatelets; Heart failure therapies; Ischaemic heart disorder therapies; Small molecules; Vasodilators
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Heart transplant rejection; Lung transplant rejection; Peptic ulcer; Renal failure
  • Discontinued Angina pectoris; Heart failure; Hypertension; Thrombosis

Most Recent Events

  • 24 May 2000 Preclinical development for Heart transplant rejection in Japan (Unknown route)
  • 13 Apr 2000 An animal study was added to the pharmacodynamic section of transplant rejection
  • 11 Apr 2000 Preclinical development for Lung transplant rejection in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top